Synthetic opioids: a review and clinical update
Therapeutic Advances in Psychopharmacology · 2022-01 · 12
DOI: 10.1177/20451253221139616 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Therapeutic Advances in Psychopharmacology, online erschienen am 10.12.2022. Verfasst von Abu Shafi und 4 weiteren Autor:innen. Beteiligte Einrichtung: South West London and Saint George's Mental Health NHS Trust, London, UK. Die Arbeit wurde bisher 75-mal zitiert (Crossref) und nennt 185 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The term ‘opioids’ refers to both the natural compounds (‘opiates’) which are extracted from the opium poppy plant ( Papaver somniferum) and their semi-synthetic and synthetic derivatives. They all possess relatively similar biochemical profiles and interact with the opioid receptors within the human body to produce a wide range of physiological effects. They have historically been used for medicinal purposes, their analgesic and sedative effects, and in the management of chronic and severe pain. They have also been used for non-medicinal and recreational purposes to produce feelings of relaxation, euphoria and well-being. Over the last decade, the emergence of an illegal market in new synthetic opioids has become a major global public health issue, associated with a substantial increase in unintentional overdoses and drug-related deaths. Synthetic opioids include fentanyl, its analogues and emerging non-fentanyl opioids. Their popularity relates to changes in criminal markets, pricing, potency, availability compared to classic opioids, ease of transport and use, rapid effect and lack of detection by conventional testing technologies. This article expands on our previous review on new psychoactive substances. We now provide a more in-depth review on synthetic opioids and explore the current challenges faced by people who use drugs, healthcare professionals, and global public health systems.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- South West London and Saint George's Mental Health NHS Trust, London, UK.
- Division of Psychiatry, University College London, London, UK.
- Liverpool John Moores University, Liverpool, UK.
- Clinical Toxicology, Guy's and St Thomas' NHS Foundation Trust, London, UK; Clinical Toxicology, Faculty of Life Sciences and Medicine, King's College London, London, UK.
- West London NHS Trust, Trust Headquarters, 1 Armstrong Way, Southall UB2 4SD, UK.
ORCID-Profile: Derek K Tracy
Zitieren
APA
Shafi, A., Berry, A. J., Sumnall, H., Wood, D. M., & Tracy, D. K. (2022). Synthetic opioids: a review and clinical update. Therapeutic Advances in Psychopharmacology, 12. https://doi.org/10.1177/20451253221139616
Vancouver
Shafi A, Berry AJ, Sumnall H, Wood DM, Tracy DK. Synthetic opioids: a review and clinical update. Therapeutic Advances in Psychopharmacology. 2022;12. doi:10.1177/20451253221139616
BibTeX
@article{Shafi2022,
author = {Shafi, Abu and Berry, Alex J and Sumnall, Harry and Wood, David M and Tracy, Derek K},
title = {Synthetic opioids: a review and clinical update},
journal = {Therapeutic Advances in Psychopharmacology},
year = {2022},
volume = {12},
doi = {10.1177/20451253221139616}
}
EUVIMED